TrialAnti-cancer drugs2015

Once-daily, oral levofloxacin monotherapy for low-risk neutropenic fever in cancer patients: a pilot study in China.

Lixian He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.